Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Novartis
Cantor Fitzgerald
Citi
Harvard Business School
Cipla
Farmers Insurance
US Army
Teva
Queensland Health

Generated: February 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,429,602

« Back to Dashboard

Summary for Patent: 7,429,602
Title:Treating conjunctivitis by topically administering an epinastine solution to the conjunctiva
Abstract:Treating allergic conjunctivitis by administered aqueous solutions containing epinastine, optionally in the form of its racemate or its enantiomers and optionally, in the form of the pharmacologically acceptable acid addition salts thereof, to the conjunctiva.
Inventor(s): Trach; Volker (Biberach, DE), Duschler; Gerold (Ehingen, DE)
Assignee: Boehringer Ingelheim Pharma GmbH & Co. Kg (Ingelheim, DE)
Application Number:11/863,008
Patent Claim Types:
see list of patent claims
Use; Formulation;

Drugs Protected by US Patent 7,429,602

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 7,429,602

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany199 54 516Nov 12, 1999

International Patents Family Members for US Patent 7,429,602

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Turkey 200201270 ➤ Try a Free Trial
Slovakia 287343 ➤ Try a Free Trial
Slovakia 8302002 ➤ Try a Free Trial
Slovenia 1231920 ➤ Try a Free Trial
Saudi Arabia 1529 ➤ Try a Free Trial
Serbia 50173 ➤ Try a Free Trial
Yugoslavia 33602 ➤ Try a Free Trial
Portugal 1231920 ➤ Try a Free Trial
Poland 198879 ➤ Try a Free Trial
Poland 364028 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Express Scripts
Baxter
Citi
Fuji
Queensland Health
Julphar
Covington
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot